Cargando…

PB.53: Are ethnic minorities more likely to develop triple-negative breast cancer? A systematic review

Detalles Bibliográficos
Autores principales:	Limbada, R, Slater, A, Jain, AK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980684/ http://dx.doi.org/10.1186/bcr3553

Ejemplares similares

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
por: Sainsbury, R, et al.
Publicado: (2010)

Systematic review of interventions to increase recruitment and retention of black, minority and ethnic patients into randomised controlled trials
por: Iqbal, Gulnaz, et al.
Publicado: (2013)

In vitro antineoplastic activity in triple-negative breast cancer cell line and in vivo
por: Madeira, Klesia, et al.
Publicado: (2014)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

PB.25. Implementation of two new digital mammography technologies for Breast Test Wales: more or less accurate?
por: Evans, T, et al.
Publicado: (2014)

Phenotypic analysis of breast cell lines – triple negative cells vs expressing hormonal receptors
por: Laranjo, Mafalda, et al.
Publicado: (2010)

Integrating GWAS with gene expression data to dissect the genetic architecture of triple-negative breast cancer
por: Hicks, Chindo, et al.
Publicado: (2011)

An integrative genomics approach for mapping the emerging genetic susceptibility landscape of triple-negative breast cancer
por: Hicks, Chindo, et al.
Publicado: (2012)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

PB.18: Factors affecting breast density assessment
por: Beattie, L, et al.
Publicado: (2013)

Impact of index of multiple deprivation and ethnicity on breast screening uptake in the North West of England
por: Bhola, Jayeshwaraj, et al.
Publicado: (2015)

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
por: Bouchalova, K, et al.
Publicado: (2011)

PB.6. Management of radial scars on core biopsy
por: Hodkin, L, et al.
Publicado: (2014)

In vivo pulmonary metastatic profile of breast cancer cell lines expressing hormonal receptors versus triple negative
por: Carvalho, M João, et al.
Publicado: (2010)

Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON
por: Hu, Zhiwei, et al.
Publicado: (2015)

TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer
por: Byrd, Tiara, et al.
Publicado: (2014)

PB.4. Ultrasound false negative preoperative axillary assessment in breast cancer patients undergoing sentinel node biopsy
por: Grosvenor, L, et al.
Publicado: (2014)

Breast cancer screening - how do we communicate with women of South Asian origin?
por: Jain, AK, et al.
Publicado: (2009)

A retrospective review of triple-negative breast cancer cases: are there common features in the clinical presentation, imaging and risk factors?
por: Trevett, N, et al.
Publicado: (2010)

PB.10: Breast compression, compressed breast thickness and volumetric breast density
por: Khan-Perez, J, et al.
Publicado: (2013)

PB.17: Inter-observer agreement in visual analogue scale assessment of percentage breast density
por: Sergeant, JC, et al.
Publicado: (2013)

P15-30 LB. An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials
por: Johnson, D, et al.
Publicado: (2009)

PB.43. A clinical audit of breast cancer staging
por: Sulistijo, A, et al.
Publicado: (2014)

PB.27. Breast screening with MRI in high-risk women
por: Howarth, D, et al.
Publicado: (2014)

PB.23. Breast density in previous screening mammograms of women with and without breast cancer
por: Sivagnanam, L, et al.
Publicado: (2014)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

PB.21: Relationship between volumetric breast density and socioeconomic status
por: Samuels, L, et al.
Publicado: (2013)

PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy
por: Santosh, D, et al.
Publicado: (2013)

PB.24. How does volumetric breast density change with time?
por: Daniels, J, et al.
Publicado: (2014)

PB.31. Occult breast carcinoma: an experience at a single unit
por: Meraj, S, et al.
Publicado: (2014)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Genome-wide profiling of copy number alterations in triple-negative breast cancer identifies a region at 19p13 associated with lymph node metastasis
por: Fidalgo, Felipe, et al.
Publicado: (2013)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

PB.46: Peutz-Jeghers Syndrome and carcinoma of the breast: call for new breast imaging surveillance guidelines
por: Tsang, FJ, et al.
Publicado: (2013)

PB.16. Breast screening mammograms: recall or not to recall. What is the golden ratio?
por: Sever, AR, et al.
Publicado: (2014)

PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast
por: Ray, A, et al.
Publicado: (2014)

PB.26. MRI-guided breast biopsy in Leeds: 12 years' experience
por: Rajan, S, et al.
Publicado: (2014)

PB.25: Relationship between volumetric breast density, age and hormonal factors
por: Johnson, PF, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n3cpgt6oiuct64v0c3555bsboo